Diabetes care startup BeatO raised $33 million in funds led by Lighrock India

Share via:

Diabetes care startup BeatO raised $33 million in funds led by Lighrock India where HealthQuad, Flipkart Ventures and existing investors including Blume Ventures and Leo Capital also participated.

BeatO offers accessible diabetes care with a focus on those who lack access to medical professionals. The company announced that it would use the new funding to expand its operations, hire top leadership, purchase hardware and software, and increase sales of its goods to more people across the nation. With more than 200 million Indians at risk for developing diabetes, the startup predicts that India will soon surpass China to become the world’s diabetes capital.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Diabetes care startup BeatO raised $33 million in funds led by Lighrock India

Diabetes care startup BeatO raised $33 million in funds led by Lighrock India where HealthQuad, Flipkart Ventures and existing investors including Blume Ventures and Leo Capital also participated.

BeatO offers accessible diabetes care with a focus on those who lack access to medical professionals. The company announced that it would use the new funding to expand its operations, hire top leadership, purchase hardware and software, and increase sales of its goods to more people across the nation. With more than 200 million Indians at risk for developing diabetes, the startup predicts that India will soon surpass China to become the world’s diabetes capital.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

Save $44 on this powerful 160W Anker Prime Charger

This is a “limited time deal” offered by Amazon. If...

Ezeepay Crosses INR 100 Crore in Transactions in Rural...

Reflecting this shift, Ezeepay has crossed INR 100 crore...

Everything Is Content for the ‘Clicktatorship’

In President Donald Trump’s second term, everything is content....

Popular

Upcoming Events

The first Windows 11 OS update for 2026 is...

2026 is officially off to the races as Microsoft's...

Voice AI Startup Deepgram Becomes $1.3B Unicorn After $130M...

In a significant milestone for the voice artificial intelligence...
iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv